These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26634417)

  • 1. Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Pitt B; Weir MR
    Eur J Heart Fail; 2016 Feb; 18(2):216. PubMed ID: 26634417
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Konstam MA
    Eur J Heart Fail; 2015 Oct; 17(10):997-9. PubMed ID: 26443125
    [No Abstract]   [Full Text] [Related]  

  • 3. Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure.
    Rafique Z; Weir MR; Onuigbo M; Pitt B; Lafayette R; Butler J; Lopes M; Farnum C; Peacock WF
    J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S10-S19. PubMed ID: 28485203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer.
    Epstein M; Pitt B
    Expert Opin Pharmacother; 2016 Jul; 17(10):1435-48. PubMed ID: 27180623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New potassium binders effective: treatment of hyperkalaemia secondary to RAAS inhibitors].
    Hoorn EJ
    Ned Tijdschr Geneeskd; 2015; 159():A8801. PubMed ID: 25761299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in treatment of hyperkalemia in chronic kidney disease.
    Sarafidis PA; Georgianos PI; Bakris GL
    Expert Opin Pharmacother; 2015; 16(14):2205-15. PubMed ID: 26330193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia.
    Pitt B; Garza D
    Expert Opin Drug Saf; 2018 May; 17(5):525-535. PubMed ID: 29667438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs to prevent and treat hyperkalemia.
    Lepage L; Desforges K; Lafrance JP
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):524-528. PubMed ID: 27584929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New agents for hyperkalemia.
    Phillips RA; Appel LJ; Weinberg JM
    N Engl J Med; 2015 Apr; 372(16):1569. PubMed ID: 25875264
    [No Abstract]   [Full Text] [Related]  

  • 11. New agents for hyperkalemia.
    Finucane TE
    N Engl J Med; 2015 Apr; 372(16):1569-70. PubMed ID: 25875265
    [No Abstract]   [Full Text] [Related]  

  • 12. A new era for the treatment of hyperkalemia?
    Ingelfinger JR
    N Engl J Med; 2015 Jan; 372(3):275-7. PubMed ID: 25415806
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral sodium and potassium binders in heart failure.
    Morris AA; Cole RT; Butler J; Gupta D
    Curr Heart Fail Rep; 2015 Apr; 12(2):107-11. PubMed ID: 25542216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New agents for hyperkalemia.
    Weir MR; Bakris GL; Pitt B
    N Engl J Med; 2015 Apr; 372(16):1570-1. PubMed ID: 25875263
    [No Abstract]   [Full Text] [Related]  

  • 15. New agents for hyperkalemia.
    Yuan CM; Little DJ; Nee R
    N Engl J Med; 2015 Apr; 372(16):1570. PubMed ID: 25875267
    [No Abstract]   [Full Text] [Related]  

  • 16. New agents for hyperkalemia.
    Synhavsky A
    N Engl J Med; 2015 Apr; 372(16):1570. PubMed ID: 25875266
    [No Abstract]   [Full Text] [Related]  

  • 17. Patiromer: A Review in Hyperkalaemia.
    Kim ES; Deeks ED
    Clin Drug Investig; 2016 Aug; 36(8):687-94. PubMed ID: 27380495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two drugs show promising results for treating hyperkalemia in US study.
    Wise J
    BMJ; 2015 Jan; 350():h278. PubMed ID: 25596538
    [No Abstract]   [Full Text] [Related]  

  • 19. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
    Weir MR; Bakris GL; Bushinsky DA; Mayo MR; Garza D; Stasiv Y; Wittes J; Christ-Schmidt H; Berman L; Pitt B;
    N Engl J Med; 2015 Jan; 372(3):211-21. PubMed ID: 25415805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperkalemia in heart failure: new solutions for an old problem].
    Romani S; Porcari A; Fabris E; Sinagra G
    G Ital Cardiol (Rome); 2019 Oct; 20(10):543-551. PubMed ID: 31593157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.